Ran Biotechnologies Inc

Arvid Therapeutics Inc located in Beverly MA offers a serene environment for relaxation and healing through professional massage therapy. With a focus on personalized care their skilled therapists use a variety of techniques to alleviate pain reduce stress and promote overall wellness. Whether you seek relief from tension or simply a moment of tranquility Arvid Therapeutics provides a rejuvenating experience tailored to your needs. Generated from this place's information

3EO Health Inc is a cutting-edge healthcare company based in Beverly, MA, specializing in providing high-performing and cost-effective diagnostic solutions. Their patented 3TR technology offers PCR-level sensitivity and specificity, enabling early detection and resilience to mutations for optimal diagnosis of infectious diseases. With their preparation-free technology and compact Cube device, 3EO simplifies the testing process, saving time and money for both physicians and consumers. Their mission is to make elite diagnostic technology accessible, available, and affordable for everyone, revolutionizing the healthcare industry. At 3EO Health Inc, they believe in creating a world where everyone can optimize their health. By offering low-cost access to game-changing molecular diagnostics at the point of care, need, and life, they aim to enhance pathways for health and care. Their innovative solutions not only deliver exceptional performance but also reduce hidden costs and complexities associated with traditional testing methods. With a commitment to better collaboration and increased access, 3EO Health Inc is revolutionizing the healthcare landscape, empowering individuals and communities to take control of their well-being.Generated from the website

Omixon Inc is a molecular diagnostics company based in Salem, MA that specializes in Next Generation Sequencing (NGS) technologies for histocompatibility labs. Their flagship product, Holotype HLA, is a combination NGS Assay and Software product designed for HLA typing and is used on Illumina sequencers. With a focus on driving innovation and improving transplant outcomes, Omixon has become a global leader in the adoption of NGS in the HLA community. Omixon's product portfolio also includes NanoTYPE, a nanopore-based long-read sequencing technology that offers a revolutionary change in the clinical routine of HLA genotyping, and NANOTYPE MONO, a single locus testing kit available as a Research Use Only (RUO) product. With a team of key opinion leaders and major collaborators in the HLA community, Omixon has trained HLA labs worldwide and has a strong presence in both Europe and North America. Their dedication to accurate and meaningful data interpretation has made them a trusted partner for laboratories seeking to advance patient care through NGS techniques.Generated from the website